1. Home
  2. UFPT vs NVAX Comparison

UFPT vs NVAX Comparison

Compare UFPT & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UFP Technologies Inc.

UFPT

UFP Technologies Inc.

HOLD

Current Price

$255.48

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$8.77

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UFPT
NVAX
Founded
1963
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
1996
1996

Fundamental Metrics

Financial Performance
Metric
UFPT
NVAX
Price
$255.48
$8.77
Analyst Decision
Strong Buy
Hold
Analyst Count
1
9
Target Price
$289.00
$11.33
AVG Volume (30 Days)
147.1K
4.4M
Earning Date
05-01-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
15.44
309.76
EPS
2.24
N/A
Revenue
$602,797,000.00
$1,123,479,000.00
Revenue This Year
$8.12
N/A
Revenue Next Year
$5.72
N/A
P/E Ratio
$112.83
N/A
Revenue Growth
19.50
64.69
52 Week Low
$173.86
$6.20
52 Week High
$274.93
$11.85

Technical Indicators

Market Signals
Indicator
UFPT
NVAX
Relative Strength Index (RSI) 71.73 44.04
Support Level $205.96 $7.94
Resistance Level $270.31 $9.02
Average True Range (ATR) 9.57 0.60
MACD 1.89 -0.09
Stochastic Oscillator 97.01 27.54

Price Performance

Historical Comparison
UFPT
NVAX

About UFPT UFP Technologies Inc.

UFP Technologies Inc is a contract development and manufacturing organization that specializes in single-use and single-patient medical devices. The company manufactures its products by converting raw materials using laminating, molding, radio frequency, and impulse welding, and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: